A more aggressive subtype was associated with frequent inactivation mutations in the TP53 gene, along with overexpression of stemness markers (KRT19 and EPCAM) and tumor marker BIRC5, and activated Wnt and PKB/Akt signaling pathways. This evidence concerns the gene AKT1 and neoplasm.